Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review

Table 2 Results of multiple regression analysis investigating the association of various clinical covariates with interpatient variability in the magnitude of increase in serum inorganic phosphorus concentration during the interdialysis interval in Japanese hemodialysis patients (n = 108)

Covariate	PRC	SE	SPRC	VIF	P
Intercept	1.56	0.95	0.0	-	0.103
Concomitant use of AR	0.374	0.119	0.313	1.21	0.002
Female	0.116	0.112	0.114	1.49	0.306
Age (years)	−0.00802	0.00815	−0.102	1.31	0.327
Dry weight (kg)	0.0124	0.0108	0.145	1.93	0.252
Daily dose of CaC (g/day)	0.0357	0.0746	−0.0473	1.19	0.633
Interdialysis interval of 72 h	0.206	0.100	0.198	1.14	0.043
Residual GFR (mL/min/1.73 m²)	0.0060	0.0410	0.0167	1.60	0.885

AR acid reducers, CaC calcium carbonates, GFR glomerular filtration rate, PRC partial regression coefficient, SE standard error of PRC, SPRC standardized partial regression coefficient, VIF variance inflation factors

ISSN: 2055-0294